Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

    Results: 1 to 20 of 32

    1.

    Stem cell transplantation in primary myelofibrosis of childhood.

    Mitton B, de Oliveira S, Pullarkat ST, Moore TB.

    J Pediatr Hematol Oncol. 2013 Apr;35(3):e120-2. doi: 10.1097/MPH.0b013e31828800cc.

    PMID:
    23511496
    [PubMed - indexed for MEDLINE]
    2.

    Associations and prognostic interactions between circulating levels of hepcidin, ferritin and inflammatory cytokines in primary myelofibrosis.

    Pardanani A, Finke C, Abdelrahman RA, Lasho TL, Tefferi A.

    Am J Hematol. 2013 Apr;88(4):312-6. doi: 10.1002/ajh.23406. Epub 2013 Feb 28.

    PMID:
    23450619
    [PubMed - indexed for MEDLINE]
    3.

    Primary myelofibrosis: 2013 update on diagnosis, risk-stratification, and management.

    Tefferi A.

    Am J Hematol. 2013 Feb;88(2):141-50. doi: 10.1002/ajh.23384. Review.

    PMID:
    23349007
    [PubMed - indexed for MEDLINE]
    4.

    A phase I study of panobinostat (LBH589) in patients with primary myelofibrosis (PMF) and post-polycythaemia vera/essential thrombocythaemia myelofibrosis (post-PV/ET MF).

    Mascarenhas J, Lu M, Li T, Petersen B, Hochman T, Najfeld V, Goldberg JD, Hoffman R.

    Br J Haematol. 2013 Apr;161(1):68-75. doi: 10.1111/bjh.12220. Epub 2013 Jan 21.

    PMID:
    23330839
    [PubMed - indexed for MEDLINE]
    5.

    Methylome profiling reveals distinct alterations in phenotypic and mutational subgroups of myeloproliferative neoplasms.

    Nischal S, Bhattacharyya S, Christopeit M, Yu Y, Zhou L, Bhagat TD, Sohal D, Will B, Mo Y, Suzuki M, Pardanani A, McDevitt M, Maciejewski JP, Melnick AM, Greally JM, Steidl U, Moliterno A, Verma A.

    Cancer Res. 2013 Feb 1;73(3):1076-85. doi: 10.1158/0008-5472.CAN-12-0735. Epub 2012 Oct 11.

    PMID:
    23066032
    [PubMed - indexed for MEDLINE]
    6.

    Clinical predictors of outcome in MPN.

    Passamonti F, Maffioli M, Merli M, Ferrario A, Caramazza D.

    Hematol Oncol Clin North Am. 2012 Oct;26(5):1101-16. doi: 10.1016/j.hoc.2012.07.009. Epub 2012 Aug 28. Review.

    PMID:
    23009940
    [PubMed - indexed for MEDLINE]
    7.

    SRSF2 mutations in primary myelofibrosis: significant clustering with IDH mutations and independent association with inferior overall and leukemia-free survival.

    Lasho TL, Jimma T, Finke CM, Patnaik M, Hanson CA, Ketterling RP, Pardanani A, Tefferi A.

    Blood. 2012 Nov 15;120(20):4168-71. doi: 10.1182/blood-2012-05-429696. Epub 2012 Sep 11.

    PMID:
    22968464
    [PubMed - indexed for MEDLINE]
    8.

    Plasma cytokines in polycythemia vera: phenotypic correlates, prognostic relevance, and comparison with myelofibrosis.

    Vaidya R, Gangat N, Jimma T, Finke CM, Lasho TL, Pardanani A, Tefferi A.

    Am J Hematol. 2012 Nov;87(11):1003-5. doi: 10.1002/ajh.23295. Epub 2012 Sep 11.

    PMID:
    22965887
    [PubMed - indexed for MEDLINE]
    9.

    Stromal SPARC contributes to the detrimental fibrotic changes associated with myeloproliferation whereas its deficiency favors myeloid cell expansion.

    Tripodo C, Sangaletti S, Guarnotta C, Piccaluga PP, Cacciatore M, Giuliano M, Franco G, Chiodoni C, Sciandra M, Miotti S, Calvaruso G, Carè A, Florena AM, Scotlandi K, Orazi A, Pileri SA, Colombo MP.

    Blood. 2012 Oct 25;120(17):3541-54. doi: 10.1182/blood-2011-12-398537. Epub 2012 Sep 5.

    PMID:
    22955913
    [PubMed - indexed for MEDLINE]
    10.

    Myeloproliferative neoplasms 2012: the John M. Bennett 80th birthday anniversary lecture.

    Tefferi A.

    Leuk Res. 2012 Dec;36(12):1481-9. doi: 10.1016/j.leukres.2012.08.011. Epub 2012 Aug 21. Review.

    PMID:
    22917768
    [PubMed - indexed for MEDLINE]
    11.

    A3669G polymorphism of glucocorticoid receptor is a susceptibility allele for primary myelofibrosis and contributes to phenotypic diversity and blast transformation.

    Poletto V, Rosti V, Villani L, Catarsi P, Carolei A, Campanelli R, Massa M, Martinetti M, Viarengo G, Malovini A, Migliaccio AR, Barosi G.

    Blood. 2012 Oct 11;120(15):3112-7. doi: 10.1182/blood-2012-05-433466. Epub 2012 Aug 9.

    PMID:
    22879541
    [PubMed - indexed for MEDLINE]
    12.

    Molecular profiling of peripheral blood cells from patients with polycythemia vera and related neoplasms: identification of deregulated genes of significance for inflammation and immune surveillance.

    Skov V, Larsen TS, Thomassen M, Riley CH, Jensen MK, Bjerrum OW, Kruse TA, Hasselbalch HC.

    Leuk Res. 2012 Nov;36(11):1387-92. doi: 10.1016/j.leukres.2012.07.009. Epub 2012 Aug 9.

    PMID:
    22877729
    [PubMed - indexed for MEDLINE]
    13.

    SETBP1 and miR_4319 dysregulation in primary myelofibrosis progression to acute myeloid leukemia.

    Albano F, Anelli L, Zagaria A, Coccaro N, Casieri P, Minervini A, Specchia G.

    J Hematol Oncol. 2012 Aug 8;5:48. doi: 10.1186/1756-8722-5-48.

    PMID:
    22873195
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    14.

    Splenomegaly in myelofibrosis--new options for therapy and the therapeutic potential of Janus kinase 2 inhibitors.

    Randhawa J, Ostojic A, Vrhovac R, Atallah E, Verstovsek S.

    J Hematol Oncol. 2012 Aug 1;5:43. doi: 10.1186/1756-8722-5-43. Review.

    PMID:
    22852872
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    15.

    Improving survival trends in primary myelofibrosis: an international study.

    Cervantes F, Dupriez B, Passamonti F, Vannucchi AM, Morra E, Reilly JT, Demory JL, Rumi E, Guglielmelli P, Roncoroni E, Tefferi A, Pereira A.

    J Clin Oncol. 2012 Aug 20;30(24):2981-7. doi: 10.1200/JCO.2012.42.0240. Epub 2012 Jul 23.

    PMID:
    22826273
    [PubMed - indexed for MEDLINE]
    16.

    Long term follow up of 93 families with myeloproliferative neoplasms: life expectancy and implications of JAK2V617F in the occurrence of complications.

    Malak S, Labopin M, Saint-Martin C, Bellanne-Chantelot C, Najman A; French Group of Familial Myeloproliferative Disorders.

    Blood Cells Mol Dis. 2012 Oct 15-Dec 15;49(3-4):170-6. Epub 2012 Jul 19.

    PMID:
    22818858
    [PubMed - indexed for MEDLINE]
    17.

    Polymorphisms of tumor necrosis factor gene in primary myelofibrosis.

    Liu L, Ai X, Xu Z, Xiao Z.

    Eur J Haematol. 2012 Oct;89(4):367-8. doi: 10.1111/j.1600-0609.2012.01836.x. Epub 2012 Aug 8. No abstract available.

    PMID:
    22779428
    [PubMed - indexed for MEDLINE]
    18.

    Current and emerging therapies in primary myelofibrosis.

    Ayyappan S, Janakiram M, Raghupathy R.

    Cardiovasc Hematol Disord Drug Targets. 2012 Sep;12(1):6-20. Review.

    PMID:
    22746348
    [PubMed - indexed for MEDLINE]
    19.

    Resorptive hypercalcemia in post-essential thrombocythemia myelofibrosis: treatment with denosumab.

    Khoury N, Chang J, Gru AA, Whyte MP.

    J Clin Endocrinol Metab. 2012 Sep;97(9):3051-5. doi: 10.1210/jc.2012-1792. Epub 2012 Jun 22.

    PMID:
    22730513
    [PubMed - indexed for MEDLINE]
    20.

    Disease characteristics and clinical outcome in young adults with essential thrombocythemia versus early/prefibrotic primary myelofibrosis.

    Barbui T, Thiele J, Carobbio A, Passamonti F, Rumi E, Randi ML, Bertozzi I, Vannucchi AM, Gisslinger H, Gisslinger B, Finazzi G, Ruggeri M, Rodeghiero F, Rambaldi A, Gangat N, Tefferi A.

    Blood. 2012 Jul 19;120(3):569-71. doi: 10.1182/blood-2012-01-407981. Epub 2012 Jun 13.

    PMID:
    22700720
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Search details

      See more...

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk